Target intelligence / Profile preview

Plasmodium falciparum cytochrome b (PfCYTB)

Target
PfCYTB
Molecular classification
Enzyme, Mitochondrial electron transport chain protein, Component of cytochrome bc1 complex (complex III)
01

Overview

Plasmodium falciparum cytochrome b (PfCYTB) is an integral membrane protein located in the mitochondrial inner membrane of the malaria parasite. It serves as a core catalytic subunit of the cytochrome bc1 complex (complex III), which is responsible for electron transfer from ubiquinol to cytochrome c as part of mitochondrial oxidative phosphorylation, generating the proton motive force needed for ATP synthesis[1][7]. It is an essential enzyme for parasite survival and a validated antimalarial drug target: inhibitors like atovaquone and several experimental quinolones exert their effect by blocking this protein’s function, leading to parasite death[3][4][5][7]. Drug resistance typically arises through single nucleotide polymorphisms in the cytochrome b gene, especially within the ubiquinol-binding pocket, making monitoring of these mutations important for treatment efficacy and development of new therapies[3][4][5][6][7].

Other names
cytochrome bCYTB
02

Mechanism of action

Inhibition of mitochondrial electron transport chain at the cytochrome bc1 complex, causing collapse of the proton gradient and cellular ATP depletion[3][4][5][6][7].

03

Biological functions

Electron transportOxidative phosphorylationCellular energy metabolism
04

Disease associations

Infection (specifically malaria)
05

Safety considerations

Rapid development of drug resistance due to point mutations in cytochrome b (especially atovaquone resistance mutations)[3][4][5][6]
06

Interacting drugs

Atovaquone

4 more in the full profile.

07

Biomarkers

Mutations in CYTB gene (associated with resistance to drugs such as atovaquone and decoquinate)[3][4][5][6]

Beyond the preview

Go deeper on Plasmodium falciparum cytochrome b (PfCYTB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum cytochrome b (PfCYTB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call